tradingkey.logo
tradingkey.logo
Search

Bionano Genomics Inc

BNGO
Add to Watchlist
1.150USD
-0.020-1.71%
Close 07/02, 13:00ETQuotes delayed by 15 min
12.97MMarket Cap
LossP/E TTM

Bionano Genomics Inc

1.150
-0.020-1.71%
View Detailed Chart
TradingKey 图表
Intraday
1m
30m
1h
D
W
M
D

Today

-1.71%

5 Days

+0.88%

1 Month

-8.73%

6 Months

-27.67%

Year to Date

-24.84%

1 Year

-65.88%

Key Figures
1.170Open
1.180High
213.78KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
1.90%Turnover Ratio
1.170Prev. Close
1.130Low
209.80KTurnover
LossP/E Static
0.35P/B
0.00%Div Yield TTM
-44.12%ROA
5.50052wk High
1.64Volume Ratio
-112.02MNet Profit
11.28MShares
-4.4524EPS TTM
1.65Beta
-73.78%ROE
1.06052wk Low
4.27%Amplitude
48.63%Gross Margin
12.97MMarket Cap
-1.68Reward/Risk
4.24%Risk Rate

TradingKey Stock Score of Bionano Genomics Inc

Currency: USD Updated: 2026-07-02

Key Insights

Bionano Genomics Inc's fundamentals are relatively stable, and its growth potential is significant.Its valuation is considered fairly valued, ranking 144 out of 204 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 5.00.In the medium term, the stock price is expected to remain stable.The company has shown weak stock market performance over the past month, in line with its weak fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Bionano Genomics Inc's Score

Industry at a Glance

Industry Ranking
144 / 204
Overall Ranking
378 / 4565
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Negative

Bionano Genomics Inc Highlights

StrengthsRisks
Bionano Genomics, Inc. is a provider of genome analysis solutions that can enable researchers and clinicians to reveal answers to challenging questions in biology and medicine. The Company offers optical genome mapping (OGM) solutions for applications across basic, translational and clinical research. It also offers a platform-agnostic software solution, which integrates sequencing and microarray data designed to provide analysis, visualization, interpretation and reporting of copy number variants, single-nucleotide variants, and absence of heterozygosity across the genome in one consolidated view. The Company additionally offers nucleic acid extraction and purification solutions using proprietary isotachophoresis (ITP) technology. The Company markets and sells OGM systems, including the Saphyr system, which delivers OGM data to enable ultra-sensitive and ultra-specific detection of all classes of structural variation (SV).
Growing
The company is in a growing phase, with the latest annual income totaling USD 28.51M.
Undervalued
The company’s latest PE is -0.26, at a low 3-year percentile range.
Institutional Buying
The latest institutional holdings are 1.17M shares, increasing 2.69% quarter-over-quarter.
Held by James Simons
Star Investor James Simons holds 0.00 shares of this stock.

Analyst Rating

Based on 2 analysts
Buy
Current Rating
5.000
Target Price
+327.35%
Upside Space

Bionano Genomics Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Bionano Genomics Inc Info

Bionano Genomics, Inc. is a provider of genome analysis solutions that can enable researchers and clinicians to reveal answers to challenging questions in biology and medicine. The Company offers optical genome mapping (OGM) solutions for applications across basic, translational and clinical research. It also offers a platform-agnostic software solution, which integrates sequencing and microarray data designed to provide analysis, visualization, interpretation and reporting of copy number variants, single-nucleotide variants, and absence of heterozygosity across the genome in one consolidated view. The Company additionally offers nucleic acid extraction and purification solutions using proprietary isotachophoresis (ITP) technology. The Company markets and sells OGM systems, including the Saphyr system, which delivers OGM data to enable ultra-sensitive and ultra-specific detection of all classes of structural variation (SV).
Ticker SymbolBNGO
CompanyBionano Genomics Inc
CEOHolmlin (R. Erik)
Websitehttps://bionano.com/

FAQs

What is the current price of Bionano Genomics Inc (BNGO)?

The current price of Bionano Genomics Inc (BNGO) is 1.15.

What is the symbol of Bionano Genomics Inc?

The ticker symbol of Bionano Genomics Inc is BNGO.

What is the 52-week high of Bionano Genomics Inc?

The 52-week high of Bionano Genomics Inc is 5.50.

What is the 52-week low of Bionano Genomics Inc?

The 52-week low of Bionano Genomics Inc is 1.06.

What is the market capitalization of Bionano Genomics Inc?

The market capitalization of Bionano Genomics Inc is 12.97M.

Is Bionano Genomics Inc (BNGO) currently rated as Buy, Hold, or Sell?

According to analysts, Bionano Genomics Inc (BNGO) has an overall rating of Buy, with a price target of 5.00.

What is the Earnings Per Share (EPS TTM) of Bionano Genomics Inc (BNGO)?

The Earnings Per Share (EPS TTM) of Bionano Genomics Inc (BNGO) is -4.85.